Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Continuing Education
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

dopamine

  • Open Access
    Imaging Dopaminergic Neurotransmission in Neurodegenerative Disorders
    Elon D. Wallert, Elsmarieke van de Giessen, Remco J.J. Knol, Martijn Beudel, Rob M.A. de Bie and Jan Booij
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 27S-32S; DOI: https://doi.org/10.2967/jnumed.121.263197
  • You have access
    Future Directions in Molecular Imaging of Neurodegenerative Disorders
    Henryk Barthel, Victor L. Villemagne and Alexander Drzezga
    Journal of Nuclear Medicine June 1, 2022, 63 (Supplement 1) 68S-74S; DOI: https://doi.org/10.2967/jnumed.121.263202
  • You have access
    Presynaptic Striatal Dopaminergic Function in Atypical Parkinsonism: A Metaanalysis of Imaging Studies
    Valtteri Kaasinen, Tuomas Kankare, Juho Joutsa and Tero Vahlberg
    Journal of Nuclear Medicine December 1, 2019, 60 (12) 1757-1763; DOI: https://doi.org/10.2967/jnumed.119.227140
  • You have access
    Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys
    Masakatsu Kanazawa, Hiroyuki Ohba, Shingo Nishiyama, Takeharu Kakiuchi and Hideo Tsukada
    Journal of Nuclear Medicine July 1, 2017, 58 (7) 1111-1116; DOI: https://doi.org/10.2967/jnumed.116.189159
  • You have access
    Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex
    Jenny Häggkvist, Miklós Tóth, Lenke Tari, Katarina Varnäs, Marie Svedberg, Anton Forsberg, Sangram Nag, Celia Dominguez, Ignacio Munoz-Sanjuan, Jonathan Bard, John Wityak, Andrea Varrone, Christer Halldin and Ladislav Mrzljak
    Journal of Nuclear Medicine April 1, 2017, 58 (4) 617-622; DOI: https://doi.org/10.2967/jnumed.116.180497
  • You have access
    Evaluation of 6-11C-Methyl-m-Tyrosine as a PET Probe for Presynaptic Dopaminergic Activity: A Comparison PET Study with β-11C-l-DOPA and 18F-FDOPA in Parkinson Disease Monkeys
    Masakatsu Kanazawa, Hiroyuki Ohba, Norihiro Harada, Takeharu Kakiuchi, Shin-ichi Muramatsu and Hideo Tsukada
    Journal of Nuclear Medicine February 1, 2016, 57 (2) 303-308; DOI: https://doi.org/10.2967/jnumed.115.161802
  • You have access
    Dorsal-to-Ventral Shift in Midbrain Dopaminergic Projections and Increased Thalamic/Raphe Serotonergic Function in Early Parkinson Disease
    Juho Joutsa, Jarkko Johansson, Marko Seppänen, Tommi Noponen and Valtteri Kaasinen
    Journal of Nuclear Medicine July 1, 2015, 56 (7) 1036-1041; DOI: https://doi.org/10.2967/jnumed.115.153734
  • You have access
    18F-MCL-524, an 18F-Labeled Dopamine D2 and D3 Receptor Agonist Sensitive to Dopamine: A Preliminary PET Study
    Sjoerd J. Finnema, Vladimir Stepanov, Ryuji Nakao, Anna W. Sromek, Tangzhi Zhang, John L. Neumeyer, Susan R. George, Philip Seeman, Michael G. Stabin, Cathrine Jonsson, Lars Farde and Christer Halldin
    Journal of Nuclear Medicine July 1, 2014, 55 (7) 1164-1170; DOI: https://doi.org/10.2967/jnumed.113.133876
SNMMI

© 2023 Journal of Nuclear Medicine

Powered by HighWire